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Iron-dependent peroxidation of rat liver microsomes, enhanced by adriamycin, was measured in the presence of increas- 
ing concentrations of a-tocopherol, b-carotene and retinol at low and high ~0,. B-Carotene and a-tocopherol inhibited 
lipid peroxidation by more than 60% when present at concentrations greater than 50 nmol/mg microsomal protein at 
both high and low p0,. Retinol inhibited peroxidation by 39% at concentrations greater than 100 nmol/mg microsomal 
protein. This maximal level of inhibition by retinol was unaltered by p0,. However, b-carotene was more effective than 
a-tocopherol or retinol at a p0, of 4 mmHg, whereas a-tocopherol was more effective under aerobic conditions. Since 
adriamycin-dependent lipid peroxidation is maximal at low pO,, &carotene may play a role in protecting against this 
process. 
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1. INTRODUCTION 
The peroxidation of lipids has been proposed as 
a mechanism by which redox-active xenobiotics, 
including the anticancer drug adriamycin, cause 
cell damage [l-3]. Adriamycin is reduced by 
cellular enzymes and enhances lipid peroxidation 
in a variety of systems [3-51, suggesting that its 
dose-limiting cardiotoxicity could be a result of 
myocyte membrane peroxidation [4-61. Recently, 
we have shown that adriamycin-dependent perox- 
idation of microsomes is 4-5-fold greater at low 
O2 partial pressures than in air [7]. Thus, lipid 
peroxidation in vivo should be favoured by low 02 
partial pressures, such as exist in active muscle 
tissue [8]. 
Lipid peroxidation is inhibited by chain- 
breaking antioxidants. a-Tocopherol, the best 
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known of these, is considered to be the major 
physiological inhibitor of lipid peroxidation [9]. 
Several in vitro studies of adriamycin-dependent 
peroxidation have shown inhibition by CY- 
tocopherol [ 10,l l] although the effects of deficien- 
cy or supplementation have been equivocal 
[ 12-151. The ability of a-tocopherol to inhibit 
lipid peroxidation declines with decreasing ~02 
[16]. In contrast, Burton and Ingold [16] have 
shown that P-carotene becomes more efficient at 
inhibiting peroxidation of linoleic acid as the ~02 
decreases. This suggests that &carotene and like 
compounds may provide better protection than cr- 
tocopherol against adriamycin-induced lipid 
peroxidation. 
To test this proposal, we have compared the 
abilities of a-tocopherol, &carotene and retinol to 
inhibit adriamycin-dependent microsomal lipid 
peroxidation in air and at low ~02. 
2. MATERIALS AND METHODS 
Biochemicals were from Sigma (St. Louis, MO) except for 
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adriamycin (from Farmitalia, Carlo Erba, Italy). Liver 
microsomes were prepared from Wistar rats according to Ern- 
ster et al. [17], and stored in 10 mM phosphate buffer (pH 7.4), 
at - 100°C. Microsomal protein was measured by the method 
of Lowry et al. [ 181. &Carotene and a-tocopherol, at the re- 
quired concentrations, were incorporated into the microsomal 
membrane by pelleting the microsomes at 105000 x g and gent- 
ly homogenising the pellet with antioxidant solubilised in 10 ~1 
chloroform, using a Potter-Elvehjem homogeniser. Once mix- 
ing was complete the microsomes were resuspended in buffer. 
When P-carotene-enriched microsomes were ultracentrifuged, 
all the &carotene spun down with the microsomes, 
demonstrating that it was incorporated into the microsomal 
membrane. Cytochrome P450 reductase activity of the 
antioxidant-enriched microsomes was standardized such that 
50 pl of each preparation, in 1 ml buffer with 100 ,uM NADPH, 
reduced cytochrome c at a rate of 3 aM/min. Procedures were 
carried out in acid-washed glassware and buffers were treated 
with chelex resin (Biorad Lab, CA) to remove adventitious iron. 
2.1. Lipid peroxidation 
Microsomes (0.5 mg protein/ml) were incubated with 
1OOrM NADPH, l.OrM FeCls and 30 pM adriamycin for 
30 min at 22°C in 10 mM phosphate buffer (pH 7.4). Reactions 
were performed in 10 ml rubber-stoppered glass tubes in which 
the ~OZ was manipulated by bubbling solution with 02-free Nt 
and replacing the requisite volume of NZ with 02 using a gas- 
tight syringe. Solutions were continually mixed by rotation. 
Lipid peroxidation was measured as A532 due to the formation 
of thiobarbituric acid-reactive products as described in [19]. 
Blanks contained adriamycin and microsomes but no NADPH 
or iron, and where appropriate, an equivalent amount of ,&- 
carotene. 
2.2. &Carotene bleaching 
Microsomes (0.5 mg), containing 25 ,uM &carotene, were in- 
cubated with 1.0 pM FeCls and 1OOpM NADPH in 1 ml 
phosphate buffer in the presence and absence of adriamycin. /3- 
Carotene bleaching was continuously monitored at 466 nm. 
3. RESULTS 
In the absence of adriamycin, addition of 
NADPH and iron to rat liver microsomes caused 
a small amount of lipid peroxidation that was 
relatively independent of pO2 (table 1). As we have 
shown previously 181, adriamycin enhanced perox- 
idation less than 2-fold in air, but 4-5-fold at ~02 
values of 4-8 mmHg (table 1). 
Both a-tocopherol and p-carotene gave a 
concentration-dependent inhibition of adriamycin- 
dependent peroxidation either at ~02 4 mmHg 
(fig.lA) or in air (fig.lB). Whereas in air LY- 
tocopherol gave more inhibition than an 
equivalent concentration of p-carotene, in low air 
p-carotene was a more efficient inhibitor. Max- 
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Table 1 
Effect of pO2 on adriamycin-dependent peroxidation of 
microsomal lipids 
PO2 0nmI-k) 34532 
_ + adriamycin 
0 0.09 0.11 
4 0.14 0.73 
8 0.15 0.70 
80 0.14 0.28 
160 0.14 0.27 
Microsomes were incubated with or without 30 PM adriamycin, 
NADPH and 1 pM FeCl3 as described in section 2. Each result 
is the mean of 4 experiments that agreed within 10% 
imum inhibition was achieved with >50 nmol of 
either antioxidantlmg microsomal protein, and the 
two together gave no greater inhibition than either 
one alone. The 02 dependence curves in fig.2 show 
c.. I( AntloxlQnt mndes/mg micr-al protein) 
Fig. 1. Effect of &carotene and cu-tocopherol concentration on 
adriamycin-enhanced microsomal lipid peroxidation at (A) 
pOz = 4 mmHg and (B) ~02 = 162 mmHg. Microsomes were 
incubated with adriamycin, NADPH, FeCls and p-carotene (0) 
or a-tocopherol (m) at the concentrations shown. Blanks due to 
antioxidant, anthracycline and microsomes incubated without 
NADPH were subtracted and percent inhibition was calculated. 
Each point is the mean for two sets of duplicates and the SD 
falls within each symbol size. 
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Fig.2. Inhibition of adriamycin-dependent microsomal lipid 
peroxidation by (0) 50 nmol/mg &carotene microsomal 
protein and (m) 50 nmol cy-tocopherol/mg microsomal protein 
under increasing pO2. Microsomes were incubated with 
adriamycin, FeCls and NADPH. Blanks due to antioxidant, 
anthracycline and microsomes incubated without NADPH were 
subtracted and percent inhibition was calculated. Each point is 
the mean for two sets of duplicates. 
that P-carotene inhibited more than a-tocopherol 
only at very low p0~. 
Maximum inhibition by retinol required 
> 100 nmol/mg microsomal protein and was 
similar at the two 02 concentrations (table 2). 
As evidence that &carotene was consumed dur- 
ing lipid peroxidation, continuous monitoring of 
Aw, showed bleaching of &carotene-enriched 
microsomes (fig.3). The rate of bleaching was 
enhanced 3-fold upon the addition of adriamycin. 
Table 2 
Effect of retinol on adriamycin-dependent peroxidation of 
microsomal ipids 
[Retinol] 
(nmol/mg microsomal protein) 
% inhibition of lipid 
peroxidation (A532) 
20 13 
40 23 
100 3-l 
100 (~702 = 162 mmHg) 39 
Microsomes were incubated with NADPH, adriamycin, FeClr 
and retinol at pO2 = 4 mmHg, except where indicated. A532 
values were read against a blank containing retinol, of the 
appropriate concentration, microsomes, and adriamycin, but 
no NADPH. Percent inhibition was calculated from A532 values 
of the complete system with and wihtout retinol. Each result is 
the mean of 2 sets of duplicates which agreed within 15% 
L 4 
0 10 
TIME (2) 
30 
Fig.3. Effect of adriamycin (ADR) on the bleaching of ,& 
carotene incorporated into microsomal membranes. In- 
cubations were with FeCls and 0.5 mg microsomes containing 
25 nmol p-carotene, in I ml buffer, under aerobic conditions. 
The spectrophotometer trace shown is representative of 3 
experiments. 
4. DISCUSSION 
This work demonstrates that P-carotene 
significantly inhibits adriamycin-dependent lipid 
peroxidation of microsomes in air. It is slightly less 
efficient than a-tocopherol, but as thepO2 declines 
and inhibition by cu-tocopherol decreases, there is 
an increase in inhibition by P-carotene. Retinol 
also inhibits adriamycin-dependent lipid peroxida- 
tion, although the degree of inhibition is similar at 
the different ~02 values. 
a-Tocopherol inhibits lipid peroxidation by 
reacting with the lipid hydroperoxy radical [16], 
thus inhibiting propagation of the chain reaction 
(reaction 3): 
LH + R’ - L’ + RH (1) 
L’ + 02 - LOO’ (2) 
LOO’ + LH - LOOH + L’ [propagation] (3) 
LOO’ + H - LOOH [termination] (4) 
The chain-breaking action of a-tocopherol is most 
efficient at high ~02 and as the ~02 decreases this 
mechanism of inhibition becomes less efficient. 
However, as this happens, antioxidants such as p- 
carotene and retinol that can compete with 02 for 
the lipid radical (L’, reaction 2) become better 
scavengers. Thus, Burton and Ingold [16] have 
proposed that this class of compound should pro- 
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vide better protection than cY-tocopherol against 
peroxidation processes occurring at low pOz. 
Since adriamycin-dependent microsomal lipid 
peroxidation is optimal at low ~02, their proposal 
implies that &carotene should be better than a- 
tocopherol at inhibiting this process. Our results 
show that this is indeed the case, although the dif- 
ferences between p-carotene and a-tocopherol are 
not as great as might be expected from the conclu- 
sions of Burton and Ingold. However, in their 
studies on linoleic acid, the greatest difference in 
relative efficiencies of P-carotene and a-tocopherol 
was between air and 02, and their results at lower 
~02 are comparable to ours. 
The observed inhibition of lipid peroxidation by 
retinol, although not enhanced under lowpO2, was 
still significant. Retinol is frequently dismissed as 
an antioxidant, because, compared with fi- 
carotene, it is ineffective at scavenging 02 [20]. 
However, this study has demonstrated that retinol 
does have antioxidant properties. 
Normal levels of P-carotene, a-tocopherol and 
retinol in chick liver are 0.17, 9.7 and 
153 nmol/mg for liver tissue, respectively [21]. 
Supplementation is able to elevate levels of all 
three 4-7-fold [21]. However, the fact that levels 
of retinol are comparatively so much higher, and 
the demonstration of antioxidant activity in this 
study, suggest that the physiological significance 
of the antioxidant activity of retinol appears to 
have been underestimated. Our results provide 
supporting evidence for the proposed antioxidant 
role for &carotene and retinol, and raise the 
possibility that they could protect against 
adriamycin-induced cardiotoxicity. Indeed, vita- 
min A in association with a-tocopherol has been 
shown to decrease cardiotoxicity of adriamycin in 
rabbits [22]. 
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